NO951772D0 - Process for the preparation of taxane derivatives, the thus obtained new taxanes as well as anti-tumor and anti-leukemia preparations containing the taxanes - Google Patents

Process for the preparation of taxane derivatives, the thus obtained new taxanes as well as anti-tumor and anti-leukemia preparations containing the taxanes

Info

Publication number
NO951772D0
NO951772D0 NO951772A NO951772A NO951772D0 NO 951772 D0 NO951772 D0 NO 951772D0 NO 951772 A NO951772 A NO 951772A NO 951772 A NO951772 A NO 951772A NO 951772 D0 NO951772 D0 NO 951772D0
Authority
NO
Norway
Prior art keywords
taxanes
leukemia
tumor
preparation
well
Prior art date
Application number
NO951772A
Other languages
Norwegian (no)
Other versions
NO951772L (en
Inventor
Jean-Dominique Bourzat
Alain Commercon
Dominique Deprez
Jean-Pierre Pulicani
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO951772D0 publication Critical patent/NO951772D0/en
Publication of NO951772L publication Critical patent/NO951772L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00Electrolytic production of organic compounds
    • C25B3/20Processes
    • C25B3/25Reduction
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B11/00Electrodes; Manufacture thereof not otherwise provided for
    • C25B11/04Electrodes; Manufacture thereof not otherwise provided for characterised by the material
    • C25B11/042Electrodes formed of a single material
    • C25B11/046Alloys
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B9/00Cells or assemblies of cells; Constructional parts of cells; Assemblies of constructional parts, e.g. electrode-diaphragm assemblies; Process-related cell features
    • C25B9/17Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof
    • C25B9/19Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms
    • C25B9/23Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms comprising ion-exchange membranes in or on which electrode material is embedded

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Metallurgy (AREA)
  • Electrochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
NO951772A 1992-11-12 1995-05-05 Process for the preparation of taxane derivatives, the thus obtained new taxanes as well as anti-tumor and anti-leukemia preparations containing the taxanes NO951772L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9213586A FR2697841B1 (en) 1992-11-12 1992-11-12 New taxane derivatives, their preparation and the pharmaceutical compositions containing them.
PCT/FR1993/001102 WO1994011547A1 (en) 1992-11-12 1993-11-10 Process for the preparation of taxane derivatives, novel taxanes so obtained and antitumour and antileukaemia compositions containing same

Publications (2)

Publication Number Publication Date
NO951772D0 true NO951772D0 (en) 1995-05-05
NO951772L NO951772L (en) 1995-05-05

Family

ID=9435452

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951772A NO951772L (en) 1992-11-12 1995-05-05 Process for the preparation of taxane derivatives, the thus obtained new taxanes as well as anti-tumor and anti-leukemia preparations containing the taxanes

Country Status (15)

Country Link
EP (1) EP0667922A1 (en)
JP (1) JPH08503261A (en)
KR (1) KR950704540A (en)
AU (1) AU5425794A (en)
CA (1) CA2149240A1 (en)
CZ (1) CZ122495A3 (en)
FI (1) FI952294A (en)
FR (1) FR2697841B1 (en)
MX (1) MX9306883A (en)
NO (1) NO951772L (en)
PL (1) PL308957A1 (en)
RU (1) RU95112464A (en)
SK (1) SK60895A3 (en)
WO (1) WO1994011547A1 (en)
ZA (1) ZA938366B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
FR2710642B1 (en) * 1993-09-29 1995-11-17 Rhone Poulenc Rorer Sa New taxoids, their preparation and the pharmaceutical compositions containing them.
FR2711369B1 (en) * 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa New taxoids, their preparation and the compositions containing them.
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
EP0914116B1 (en) * 1996-05-22 2000-10-11 Protarga Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
KR101535395B1 (en) * 2004-01-22 2015-07-08 유니버시티 오브 마이애미 Topical co-enzyme q10 formulations and methodns of use
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
EA201101519A1 (en) 2009-05-11 2012-10-30 БЕРГ БАЙОСИСТЕМЗ, ЭлЭлСи METHODS OF DIAGNOSTICS OF METABOLIC DISTURBANCES USING EPIMETABOLIC SWITCHES, MULTIPLE-DIFFERENT INTRACELLULAR MOLECULES OR IMPACT FACTORS
JP6092844B2 (en) 2011-04-04 2017-03-08 バーグ エルエルシー Treatment of central nervous system tumors
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
BR112015025424A2 (en) 2013-04-08 2017-07-18 Berg Llc cancer treatment using coenzyme q10 combination therapies
JP6595478B2 (en) 2013-09-04 2019-10-23 バーグ エルエルシー Cancer treatment by continuous injection of coenzyme Q10

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (en) * 1986-07-17 1988-09-23 Rhone Poulenc Sante TAXOL DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
AU5425794A (en) 1994-06-08
ZA938366B (en) 1994-06-13
MX9306883A (en) 1995-01-31
SK60895A3 (en) 1996-03-06
WO1994011547A1 (en) 1994-05-26
EP0667922A1 (en) 1995-08-23
KR950704540A (en) 1995-11-20
FI952294A0 (en) 1995-05-11
FR2697841B1 (en) 1995-01-13
JPH08503261A (en) 1996-04-09
RU95112464A (en) 1997-02-20
CZ122495A3 (en) 1995-12-13
CA2149240A1 (en) 1994-05-26
FI952294A (en) 1995-05-11
FR2697841A1 (en) 1994-05-13
PL308957A1 (en) 1995-09-04
NO951772L (en) 1995-05-05

Similar Documents

Publication Publication Date Title
NO951772D0 (en) Process for the preparation of taxane derivatives, the thus obtained new taxanes as well as anti-tumor and anti-leukemia preparations containing the taxanes
NO894929D0 (en) TOOLS FOR TREATMENT OF SUBSTANCES.
FI941137A0 (en) 2-debenzoyl-2-acyl taxol derivatives and processes for their preparation
NO900439D0 (en) PROCEDURE FOR THE TREATMENT OF INORGANIC POWDER.
FI954383A (en) Process for the preparation of cancer vaccines
NO951283D0 (en) New taxane derivatives, their preparation as well as pharmaceutical preparations containing the derivatives
FI952585A0 (en) Process for the preparation of benzopyran compounds
NO891151D0 (en) ARYLPIPERAZINYLALCOXY DERIVATIVES OF CYCLIC IMIDES, AND PROCEDURES FOR PREPARING THEREOF.
FI940775A (en) Process for the preparation and use of alpha-phenylisoserine derivatives
FI901422A0 (en) ANORDINATION OF FOERFARANDE FOER REGLERING AV DRIFT AV KLAEDESTORKARE.
NO901813L (en) PROCEDURE FOR THE PREPARATION OF NEW TIENO-TRIAZOLO-DIAZEPINE DERIVATIVES.
NO180308C (en) Process for the preparation of an approximate non-racemic form of furo (3,4-c) pyridine derivatives
NO900074D0 (en) PROCEDURE FOR THE PREPARATION OF NEW TETRALIN DERIVATIVES.
FI951561A (en) New 17-Substituted 4-Androstane Derivatives, Pharmaceutical Compositions Containing Them, and Process for Preparing the Same
AU3760489A (en) Derivatives of cyclic amp as treatment for cancer
ZA919224B (en) Process for preparing taxane derivatives,new derivatives obtained and pharmaceutical compositions containing them
FI931845A (en) PROCEDURE FOR THE PRODUCTION OF VEGETABLES AVAILABLE
FI961178A (en) Process for the preparation of cyclic cis-1-amino-2-alkanols
FI906324A0 (en) PROCEDURE FOR THE PRODUCTION OF ARTICLES AVAILABLE.
FI870089A0 (en) ANORDINATION FOR ADJUSTMENT OF DOORS AND CONTAINERS.
NO940247D0 (en) Process for the preparation of 13-cinnamoyl baccatin III or 10-deacetyl baccatin III
FI891100A0 (en) PROCESS OCH ANGELING FOR BEHANDLING AV EN GASSTROEM INNEHAOLLANDE SJAELVANTAENDBART DAMM.
FI892291A0 (en) Process for Preparation of 6-Phenoxymethyl-4-hydroxy-tetrahydropyran-2-one and 6-thiophenoxymethyl-4-hydroxy-tetrahydropyran-2-one
FI871479A0 (en) Process for the preparation of derivatives of perhydrotiazepine and perhydroazepine useful as pharmaceuticals
NO903329D0 (en) ASYMMETRIC SYNTHESIS OF FURO (3,4-C) PYRIDINE DERIVATIVES.